| Name | Title | Contact Details |
|---|---|---|
Marcel Konrad |
Chief Financial Officer | Profile |
Neurotrope is discovering restorative therapeutics for patients with life-altering neurodegenerative diseases and development disorders. We are a clinical-stage biotech company leveraging Bryostatin-1 and its analogues to discover and develop targeted therapeutics for neurodegenerative diseases and developmental disorders. Our experience and passion for novel drug therapies have enabled us to develop a pipeline that includes various treatment approaches for serious and difficult-to-treat diseases such as Alzheimer`s Disease, Fragile X Syndrome and Niemann-Pick Type C
Bridge Laboratories is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Rhoads Pharmacy is a Hummelstown, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
We are a dynamic organization committed to providing compassionate, high-quality healthcare across the Northern California East Bay.
Amylyx is a Cambridge-based pharmaceutical company dedicated to the development of therapeutics for the treatment of neurodegenerative disorders. Guided by our core values, we incorporate unconventional approaches through strong partnerships with industry leaders, scientists, doctors and organizations. We work collaboratively across everything we do to positively impact the lives of patients and their families.